loading page

Neuroimaging findings in MOGAD -- MRI and OCT
  • +3
  • Frederik Bartels,
  • Angelo Lu,
  • Frederike Oertel,
  • Carsten Finke,
  • Friedemann Paul,
  • Claudia Chien
Frederik Bartels
Charité Universitätsmedizin Berlin

Corresponding Author:frederik.bartels@charite.de

Author Profile
Angelo Lu
Max-Delbruck-Centrum fur Molekulare Medizin in der Helmholtz-Gemeinschaft
Author Profile
Frederike Oertel
Max-Delbruck-Centrum fur Molekulare Medizin in der Helmholtz-Gemeinschaft
Author Profile
Carsten Finke
Charité Universitätsmedizin Berlin
Author Profile
Friedemann Paul
Max-Delbruck-Centrum fur Molekulare Medizin in der Helmholtz-Gemeinschaft
Author Profile
Claudia Chien
Max-Delbruck-Centrum fur Molekulare Medizin in der Helmholtz-Gemeinschaft
Author Profile

Abstract

Summary Myelin oligodendrocyte glycoprotein antibody associated disorders (MOGAD) are rare in both children and adults, and have been recently suggested to be an autoimmune neuroinflammatory group of disorders that are different from aquaporin-4 autoantibody associated neuromyelitis optica spectrum disorder and from classic multiple sclerosis. In vivo imaging of the MOGAD patient central nervous system has shown some distinguishing features when evaluating magnetic resonance imaging of the brain, spinal cord, optic nerves, as well as retinal imaging using optical coherence tomography. In this review, we discuss key clinical and imaging characteristics of paediatric and adult MOGAD. We describe how these imaging techniques may be used to study this group of disorders and discuss how these imaging methods have led to recent insights for consideration in future studies.